Other
Platelet Function
0
Pipeline Programs↗
2
Active Trials↗
4
Companies Involved↗
Platelet Function is an early-stage landscape with 0 programs across 4 companies. The most active players are Merck & Co., Boehringer Ingelheim, Javelin Pharmaceuticals.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
33
clinical trials
Completed26 · 79%
Unknown status3 · 9%
Withdrawn2 · 6%
Recruiting2 · 6%
Clinical Trials
Trial Activity
33 trials
Effect of Tofacitinib on Coagulation and Platelet Function, and Its Role in Thromboembolic Events
Recruiting·FFundación de Investigación Biomédica - Hospital Universitario de La Princesa·Phase 4·NCT05313620·30 enrolled
Choice of Anticoagulant for Primary Hemostasis Studies With PFA200® (Platelet Function Analyser)
Recruiting·—·N/A·NCT06753838·100 enrolled
Effects of Fish Oil on Platelet Function and Coagulation
Completed·—·N/A·NCT03048981·12 enrolled
Study of Platelet Function After Administration of Aspirin Versus Lysine Acetylsalicylate
Completed·—·Phase 1·NCT02243137·30 enrolled
Page 1 of 3
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)